Toxoplasmosis in pregnancy: test, treatment and outcome

Objectives: The aim of this study was to share the results, follow-up, and treatment characteristics our pregnant women who were followed-up with anti-Toxoplasma gondii Immunoglobulin (Ig) M positivity during pregnancy. Methods: Anti-T. IgM- IgG-positive evaluated between 2014-2018. Demographic characteristics, treatment, information about pregnancy obtained from electronic database. Pregnant divided into three groups; primary infection, no suspected infection in Primary followed up congenital toxoplasmosis risky Fetal ultrasonography (USG), T. DNA polymerase chain reaction (PCR) result amniotic fluid recorded. Results: Twenty-four a mean age 27.9 years up. IgG avidity results low 37.5% (n = 9), intermediate 8.3% 2), high 54.2% 13) women. Eleven (45.9%) had USG performed on ten women, signs found. Amniocentesis 72.7% 8) participants, DNA-PCR negative all them. Ten (90.9%) pregnancies resulted mature birth one (9.1%) miscarriage. Conclusions: IgM is an indication acute infection. But can persist for years, be false-positive Therefore, additional tests are required, leading emotional distress unnecessary interventions pregnacy These aid developing approach screening diagnosis